NCT05229003 2024-07-03Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRCFudan UniversityPhase 2 Recruiting44 enrolled
NCT04271813 2024-04-23Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)Shanghai Changzheng HospitalPhase 2 Completed30 enrolled